(Fighting New Coronary Pneumonia) South African National Institute of Infectious Diseases: Test whether the vaccine is effective against the mutant virus
China News Service, Johannesburg, January 10 (Reporter Wang Xi) The South African National Institute of Infectious Diseases confirmed on the 10th: South African medical experts are currently testing the new coronary pneumonia vaccine that will be put into use to determine whether the vaccine will mutate The new crown pneumonia virus is effective.
A few days ago, South African Minister of Health Mukez announced that South Africa has confirmed that it will receive a total of 1.5 million new crown pneumonia vaccines this month and February, and will strive to complete the vaccination of more than 40 million people this year.
However, because the South African new crown pneumonia virus has mutated and is more contagious, whether the vaccine that will be put into use can effectively defend against the mutated virus has attracted attention from the outside world.
Earlier, British health experts pointed out that they expressed concern about whether the vaccine is effective against the mutated virus.
According to Penny Moore, a professor at the National Institute of Infectious Diseases of South Africa, South African medical experts have now completed the collection of vaccine samples from several major brands in the world, such as Pfizer and Johnson & Johnson, and will test whether vaccine antibodies will occur due to "encounters" with mutant viruses. Reduced, the test results are expected to be released within two weeks, and this will help the upcoming South African new crown pneumonia vaccination program.
As of press time, the total number of confirmed cases of new coronary pneumonia in South Africa has reached 1,214,176 and 32,824 deaths. Both continue to rank first on the African continent, and the epidemic prevention situation is not optimistic.